Background Vagal nerve blockade (vBloc) therapy was shown to be a safe and effective
treatment for moderate to severe obesity. This report summarizes the safety and efficacy of …

Abstract Background The ReCharge Trial demonstrated that a vagal blocking device (vBloc)
is a safe and effective treatment for moderate to severe obesity. This report summarizes 24 …

Background/Objectives. Vagal block therapy (vBloc) is effective for moderate to severe
obesity at one year. Subjects/Methods. The ReCharge trial is a double‐blind, randomized …

Background Intermittent, reversible intraabdominal vagal blockade (VBLOC® Therapy)
demonstrated clinically important weight loss in feasibility trials. EMPOWER, a randomized …

The following statement is issued by the American Society for Metabolic and Bariatric
Surgery in response to a recent approval by the US Food and Drug Administration (FDA) of …

Importance Although conventional bariatric surgery results in weight loss, it does so with
potential short-term and long-term morbidity. Objective To evaluate the effectiveness and …

Abstract Background Recently, the US FDA has approved “vagal blocking therapy or
vBLoc® therapy” as a new treatment for obesity. The aim of the present study was to study …

Background. An active device that downregulates abdominal vagal signalling has resulted
in significant weight loss in feasibility studies. Objective. To prospectively evaluate the effect …

Background An implantable device that intermittently blocks intra-abdominal vagal trunks
has been shown to cause significant excess weight loss (EWL) in obese subjects. The aim of …

BACKGROUND: A laparoscopically implantable electrical device that intermittently blocks
both vagi near the esophagogastric junction led to significant excess weight loss (EWL) in …